Try our beta test site

Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
CURE Childhood Cancer, Inc.
Information provided by (Responsible Party):
St. Jude Children's Research Hospital
ClinicalTrials.gov Identifier:
NCT01576692
First received: April 10, 2012
Last updated: February 22, 2017
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2019
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)